2025

Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in Canada

Mariam Z. El Sheikh, Jim Young, Dimitra Panagiotoglou, Curtis Cooper, Joseph Cox, Valérie Martel‑Laferrière, Sharon Walmsley, Marina B. Klein Can Liver J. 2025 Feb 25;8(1):49-62. doi: 10.3138/canlivj-2024-0042. PMID: 40678661; PMCID: PMC12269190.

Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in Canada Lire la suite »

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives

Bédard K, Boisvert I, Rochette M, Racine E, Martel-Laferrière V. BMC Infect Dis. 2025 Feb 14;25(1):221. doi: 10.1186/s12879-025-10617-y. PMID: 39953410; PMCID: PMC11829365. CONSULTER

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives Lire la suite »

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D. Harm Reduct J. 2025 Feb 8;22(1):14. doi: 10.1186/s12954-025-01157-4. PMID: 39923043; PMCID: PMC11806552.

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study Lire la suite »

Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022

Zolopa C, Brothers TD, Leclerc P, Mary JF, Morissette C, Bruneau J, Martin NK, Hyshka E, Larney S. Int J Drug Policy. 2025 Mar;137:104711. doi: 10.1016/j.drugpo.2025.104711. Epub 2025 Jan 21. PMID: 39842392

Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022 Lire la suite »

Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial

Conrod P, Stewart SH, Seguin J, Pihl R, Masse B, Spinney S, Lynch S. Am J Psychiatry. 2025 Jan 15:appiajp20240042. doi: 10.1176/appi.ajp.20240042. Epub ahead of print. PMID: 39810554

Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial Lire la suite »